Global Drug Eluting Stents(DES) Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Drug Eluting Stents(DES) Market Overview

1.1 Drug Eluting Stents(DES) Definition

1.2 Global Drug Eluting Stents(DES) Market Size Status and Outlook (2019-2032)

1.3 Global Drug Eluting Stents(DES) Market Size Comparison by Region (2019-2032)

1.4 Global Drug Eluting Stents(DES) Market Size Comparison by Type (2019-2032)

1.5 Global Drug Eluting Stents(DES) Market Size Comparison by Application (2019-2032)

1.6 Global Drug Eluting Stents(DES) Market Size Comparison by Sales Channel (2019-2032)

1.7 Drug Eluting Stents(DES) Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Drug Eluting Stents(DES) Market Snapshot

2.2 Global Drug Eluting Stents(DES) Market Volume & Revenue (2019-2025)

2.3 Global Drug Eluting Stents(DES) Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Drug Eluting Stents(DES) Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Drug Eluting Stents(DES) Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Drug Eluting Stents(DES) Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Drug Eluting Stents(DES) Market Segment Analysis by Player

3.1 Global Drug Eluting Stents(DES) Sales and Market Share by Player (2023-2025)

3.2 Global Drug Eluting Stents(DES) Revenue and Market Share by Player (2023-2025)

3.3 Global Drug Eluting Stents(DES) Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Drug Eluting Stents(DES) Market Segment Analysis by Type

4.1 Global Drug Eluting Stents(DES) Market by Type

4.1.1 Cobalt-chromium Alloy Stents

4.1.2 Magnesium Alloy Stents

4.1.3 Tyrosine Polycarbonate Stents

4.1.4 Nitinol Stents

4.1.5 Platinum Chromium Alloy Stents

4.1.6 Stainless Steel Stents

4.1.7 Other Materials

4.2 Global Drug Eluting Stents(DES) Sales and Market Share by Type (2019-2025)

4.3 Global Drug Eluting Stents(DES) Revenue and Market Share by Type (2019-2025)

4.4 Global Drug Eluting Stents(DES) Average Price by Type (2019-2025)

4.5 Leading Players of Drug Eluting Stents(DES) by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Drug Eluting Stents(DES) Market Segment Analysis by Application

5.1 Global Drug Eluting Stents(DES) Market by Application

5.1.1 Coronary Heart Disease

5.1.2 Clinical

5.2 Global Drug Eluting Stents(DES) Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Drug Eluting Stents(DES) by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Drug Eluting Stents(DES) Market Segment Analysis by Sales Channel

6.1 Global Drug Eluting Stents(DES) Market by Sales Channel

6.1.1 Global Drug Eluting Stents(DES) Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Drug Eluting Stents(DES) Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Drug Eluting Stents(DES) Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Drug Eluting Stents(DES) by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Drug Eluting Stents(DES) Market Segment Analysis by Region

7.1 Global Drug Eluting Stents(DES) Market Size and CAGR by Region (2019-2032)

7.2 Global Drug Eluting Stents(DES) Sales and Market Share by Region (2019-2025)

7.3 Global Drug Eluting Stents(DES) Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Drug Eluting Stents(DES) Market Share by Type

7.4.3 North America Drug Eluting Stents(DES) Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Drug Eluting Stents(DES) Market Share by Type

7.5.3 Europe Drug Eluting Stents(DES) Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Drug Eluting Stents(DES) Market Share by Type

7.6.3 Asia-Pacific Drug Eluting Stents(DES) Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Drug Eluting Stents(DES) Market Share by Type

7.7.3 South America Drug Eluting Stents(DES) Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Drug Eluting Stents(DES) Market Share by Type

7.8.3 Middle East & Africa Drug Eluting Stents(DES) Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Drug Eluting Stents(DES) Players

8.1 Abbott Vascular

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Advantec Vascular

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 B.Braun Melsengen AG

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Biosensors

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Biotronik

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Blue Medical

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Boston Scientific

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 DISA Vascular

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Essen

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Medtronic Vascular

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 MicroPort Medical

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 MIV Therapeutics

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Orbusneich

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Promed Medical

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 Relisys Medical

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

8.16 Reva Medical

8.16.1 Company Snapshot

8.16.2 Product/Service Offered

8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.16.4 Recent Developments

8.17 Sahajanand

8.17.1 Company Snapshot

8.17.2 Product/Service Offered

8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.17.4 Recent Developments

8.18 Sino Medical

8.18.1 Company Snapshot

8.18.2 Product/Service Offered

8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.18.4 Recent Developments

8.19 Sorin

8.19.1 Company Snapshot

8.19.2 Product/Service Offered

8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.19.4 Recent Developments

8.20 Terumo Medical

8.20.1 Company Snapshot

8.20.2 Product/Service Offered

8.20.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.20.4 Recent Developments

8.21 Others

8.21.1 Company Snapshot

8.21.2 Product/Service Offered

8.21.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.21.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Drug Eluting Stents(DES)

9.1 Industrial Chain of Drug Eluting Stents(DES)

9.2 Upstream of Drug Eluting Stents(DES)

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Drug Eluting Stents(DES)

9.3.1 Leading Distributors/Dealers of Drug Eluting Stents(DES)

9.3.2 Leading Consumers of Drug Eluting Stents(DES)

Chapter 10. Global Drug Eluting Stents(DES) Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Drug Eluting Stents(DES) Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Drug Eluting Stents(DES) Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Drug Eluting Stents(DES) (2026-2032)

11.1 Global Drug Eluting Stents(DES) Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Drug Eluting Stents(DES) Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Drug Eluting Stents(DES) Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Drug Eluting Stents(DES) Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Drug Eluting Stents(DES) Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Drug Eluting Stents(DES) Import-Export (2019-2025)

12.2 Europe Drug Eluting Stents(DES) Import-Export (2019-2025)

12.3 Asia Pacific Drug Eluting Stents(DES) Import-Export (2019-2025)

12.4 South America Drug Eluting Stents(DES) Import-Export (2019-2025)

12.5 Middle East & Africa Drug Eluting Stents(DES) Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Drug Eluting Stents(DES) Demand-Supply (2019-2025)

13.2 Europe Drug Eluting Stents(DES) Demand-Supply (2019-2025)

13.3 Asia Pacific Drug Eluting Stents(DES) Demand-Supply (2019-2025)

13.4 South America Drug Eluting Stents(DES) Demand-Supply (2019-2025)

13.5 Middle East & Africa Drug Eluting Stents(DES) Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources